Medirose Drugs And Pharmaceuticals Private Limited - Company Profile

It is a paper private limited company based in New Delhi, Delhi, India, established in 2024.
2024 New Delhi, Delhi, India Active
Last Updated:
About Medirose Drugs And Pharmaceuticals Private Limited

Medirose Drugs And Pharmaceuticals Private Limited, a active private limited company, was established on 21 February 2024 in New Delhi, Delhi, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21000DL2024PTC427155. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.

Its leadership includes Rajesh Kumar Soni (Director), Ruchi Rani (Director). It is based at Office No. 53, Plot No. 113,31 And 34/433, Veer Savarkar Block, Shakarpur, New Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21000DL2024PTC427155

  • Registration Number

    427155

  • Incorporation Date

    21 February 2024

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹2.00 Cr

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 2 Year, 26 Days
Company report

Medirose Drugs And Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medirose Drugs And Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Medirose Drugs And Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajesh Kumar Soni Director 21 Feb 2024 Current
Ruchi Rani Director 21 Feb 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medirose Drugs And Pharmaceuticals.

Enhance accessibility to Medirose Drugs And Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Medirose Drugs And Pharmaceuticals revenue growth over time
Medirose Drugs And Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medirose Drugs And Pharmaceuticals?

Unlock access to Medirose Drugs And Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Medirose Drugs And Pharmaceuticals?

Unlock and access historical data on people associated with Medirose Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medirose Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medirose Drugs And Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medirose Drugs And Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Rajesh Kumar Soni was appointed as a Director was appointed as a Director on 21 Feb 2024 & has been associated with this company since 2 years 26 days . was completed.

  • Director Appointment

    The activity Ruchi Rani was appointed as a Director was appointed as a Director on 21 Feb 2024 & has been associated with this company since 2 years 26 days . was completed.

  • Company Incorporation

    Progress on Medirose Drugs And Pharmaceuticals Private Limited was registered on 21 Feb 2024 with Roc Delhi I & aged 2 years 26 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medirose Drugs And Pharmaceuticals Private Limited?

The CIN of Medirose Drugs And Pharmaceuticals Private Limited is U21000DL2024PTC427155.

Where is Medirose Drugs And Pharmaceuticals Private Limited headquartered?

Medirose Drugs And Pharmaceuticals Private Limited is headquartered at Office No. 53, Plot No. 113,31 And 34/433, Veer Savarkar Block, Shakarpur, New Delhi, Delhi, 110092.

When was Medirose Drugs And Pharmaceuticals Private Limited incorporated?

Medirose Drugs And Pharmaceuticals Private Limited was incorporated on 21 February 2024.

Who are the current directors of Medirose Drugs And Pharmaceuticals Private Limited?

The current directors of Medirose Drugs And Pharmaceuticals Private Limited are

What is the primary industry of Medirose Drugs And Pharmaceuticals Private Limited?

The primary industry of Medirose Drugs And Pharmaceuticals Private Limited is Paper.

Is Medirose Drugs And Pharmaceuticals Private Limited a listed company?

Medirose Drugs And Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Medirose Drugs And Pharmaceuticals Private Limited?

The authorized capital of Medirose Drugs And Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available